Reduce early Parkinsons motor symptoms
- Trial ID
- NCT06874803
- Official Title
- Effect of "Qi-Tonifying, Yang-Warming, and Water-Resolving" Acupuncture and Moxibustion for Motor Symptom Improvement in Early Parkinson's Disease (WARMED): A Randomized Controlled Trial
- Goal
- Reduce early Parkinsons motor symptoms
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Jiani Wu
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson's Disease (PD)
- Interventions
- Acupuncture and Moxibustion (AM), Sham Acupuncture and Moxibustion (Sham-AM)
Plain-Language Summary
It tests whether a traditional acupuncture plus moxibustion protocol that aims to "tonify qi, warm yang, and resolve water" can improve motor symptoms in people with early, mild-to-moderate Parkinson's. The treatment uses needles at specific points together with localized heat from burning mugwort to stimulate nerves and tissues, and investigators think that sensory stimulation may alter brain and spinal cord signaling, muscle control, or local inflammation; they compare real treatment to a sham procedure to see if effects are specific. Because it is non-drug, it would be used alongside usual Parkinson medications like levodopa rather than replacing them. Enrollment is for people aged 30 to 80 with PD by the 2016 Chinese criteria and Hoehn-Yahr stage under 3, excluding Parkinson-plus syndromes, prior DBS, severe medical or psychiatric conditions, bleeding disorders, recent acupuncture, pregnancy, or recent trial participation.
Locations
- Guang'anmen Hospita, China Academy of Chinese Medical Sciences, Beijing, Beijing Municipality, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Acupuncture and Moxibustion (AM). It tests whether a traditional acupuncture plus moxibustion protocol that aims to "tonify qi, warm yang, and resolve water" can improve motor symptoms in people with early, mild-to-moderate Parkinson's. The treatment uses needles at specific points together with localized heat from burning mugwort to stimulate nerves and tissues, and investigators think that sensory stimulation may alter brain and spinal cord signaling, muscle control, or local inflammation; they compare real treatment to a sham procedure to see if effects are specific. Because it is non-drug, it would be used alongside usual Parkinson medications like levodopa rather than replacing them. Enrollment is for people aged 30 to 80 with PD by the 2016 Chinese criteria and Hoehn-Yahr stage under 3, excluding Parkinson-plus syndromes, prior DBS, severe medical or psychiatric conditions, bleeding disorders, recent acupuncture, pregnancy, or recent trial participation.
- Who can participate?
- Participants must be between 30 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 1 month.